Gokshura (Tribulus) and Pregnancy: A Precautionary Contraindication

Gokshura (Tribulus terrestris) is not recommended during pregnancy. Here caution is above all a precautionary contraindication: human data specific to pregnancy are lacking, but several studies and regulatory reports mention a possible effect on reproduction at high doses, enough to justify avoiding this herb during this period.

What cellular toxicity studies show

A study published in 2014 in the journal Pharmaceutical Biology assessed the toxic potential of Tribulus terrestris in vitro, measuring in particular its genotoxic activity (ability to damage cell DNA) and cytotoxicity through standardized laboratory tests (see the study on Google Scholar). This type of result, obtained on cells in a laboratory setting, does not automatically translate into a proven risk for humans at usual doses, but it feeds into broader regulatory vigilance around this herb.

A herb under international regulatory watch

Gokshura is among the herbs that have been subject to requests for restriction or oversight in some countries, due to a suspected genotoxic, mutagenic or reproductive toxicity potential at high doses, which has drawn international regulatory interest. This kind of regulatory signal, even without definitive scientific certainty, is an additional argument for strict caution during pregnancy, a period where the tolerated margin of error is at its lowest.

Traditional Ayurvedic use is not centered on fertility

It is worth remembering that Ayurvedic tradition has never presented gokshura as a fertility herb or a hormonal booster: its classical use concerns the urinary tract, joint comfort and general vitality, as detailed in our article gokshura. It is recent Western sports marketing that built a "testosterone booster" reputation around "tribulus," a reputation far more commercial than traditional — a useful distinction so as not to over-interpret the available signals in either direction.

What we know	Level of evidence
Genotoxic/cytotoxic activity in vitro at certain concentrations	Laboratory study, 2014
Regulatory reports on potential reproductive toxicity	International vigilance, no definitive conclusion
Clinical safety study in pregnant women	None identified to date
Traditional Ayurvedic use for fertility	Not documented; historical use centered on the urinary tract

Should you worry after a one-off course before pregnancy?

A course of gokshura taken before conception, at a usual dose and for a limited duration, should not be a source of disproportionate retrospective worry: the signals mentioned above mainly concern high-dose or prolonged exposures, not a past, one-off use. Once pregnancy is confirmed, the simple rule remains to stop the herb and, if in doubt, talk to your midwife or doctor.

A caution to put in perspective with sports supplements

Tribulus sold as a sports supplement is often offered at concentrations and doses well above traditional Ayurvedic use in powder or decoction form. It is precisely at these concentrated doses that the cellular toxicity signals and regulatory alerts mentioned above matter most — an additional reason to fully avoid this type of supplement during pregnancy, including those marketed as "natural" or "herbal."

What about during breastfeeding?

Data are also lacking for this period. As a precaution, and given the regulatory vigilance signals noted above, it is best to avoid regular use during breastfeeding, unless advised otherwise by a health professional.

Precautions

In summary, gokshura should be avoided during pregnancy as a precaution: no safety study is available in pregnant women, while a cellular toxicity study and several international regulatory reports mention a potential for reproductive toxicity at high doses. For traditional uses and dosage outside pregnancy, see gokshura dosage; for all safety rules, our safety and precautions guide.